Summary.-We have developed a technique for the immunocytochemical staining of marrow smears using antiserum to epithelial membrane antigen (EMA). This membrane component is confined to, but widely distributed in, epithelial tissues and tumours derived from them, and is strongly expressed by infiltrating breast carcinoma cells. Marrow aspirates from patients with both early and metastatic breast cancer have been examined, and the results of immunocytochemical staining compared with conventional cytology and histology. Staining with antiserum to EMA enabled us to detect small numbers of carcinoma cells, and increased the yield of positive samples. Furthermore, using this technique, we found malignant cells in the marrow of patients with primary breast cancer with no other evidence of metastatic disease. Thus immunocytochemical staining for EMA may be of value in the detection of micrometastases in patients with primary breast carcinoma.
THE LOCALIZATION of a cell-surface component, which has been called epithelial membrane antigen (EMA), has been described in both normal and neoplastic tissue, using an antiserum raised against human milk-fat-globule membranes (Heyderman et al., 1979; Sloane & Ormerod, 1981) . In formalin-fixed paraffinembedded sections, the antigen is confined to, but widely distributed in, epithelial tissues and tumours derived from them. Primary and metastatic breast carcinomas almost always express the antigen (Sloane & Ormerod, 1981) and single cells in infiltrates have been found to stain especially strongly with antisera to EMA.
Normal and neoplastic, haemopoietic, lymphoid, osseous and other connective tissues do not express EMA.
Antiserum to EMA has been used to facilitate detection of micrometastases in histological tissue section. Examination of blocks of marrow aspirates from patients with metastatic breast cancer led to the identification of single malignant cells, which increased the yield of positive samples by 21% (Sloane et al., 1980) . When only small numbers of malignant cells are present, taking a section from a tissue block introduces considerable sampling errors. Diagnostic yield might further improve by using the antiserum on marrow smears, when the entire aspirated sample may be examined.
In this paper we describe a method of preparing marrow aspirates in a form suitable for subsequent immunocytochemical staining, and demonstrate the value of antisera to EMA in identifying marrow metastases in patients with breast cancer.
PATIENTS AND METHODS
Patients-Seventy-four marrow aspirates from 71 patients with breast cancer were examined. At the time of sampling patients fell into 3 categories:
(1) 20 patients with primary cancer without evidence of metastatic spread, (2) 10 patients without evidence of metastases when undergoing staging investigations during follow-up after primary treatment; and (3) 44 patients with metastatic breast cancer, including 24 with bone metastases.
All these patients were staged as previously described (Coombes et al., 1980) . Bone metastases were diagnosed after radiological skeletal survey and isotope bone scan using 99mtechnetium diphosphonate.
Marrow aspirates.-All aspirates were obtained from the posterior iliac crest. Air-dried smears were made for routine cytological examination and subsequently stained automatically with May-Grunwald Giemsa stain. An aliquot of the remaining sample was processed for immunocytochemistry, and the rest of the aspirate was fixed, embedded, sectioned and stained with haematoxylin and eosin (Luke's preparation) as previously described (Sloane et al., 1980 
RESULTS
On the smears stained with anti-EMA, clumps of cells, which on morphological grounds could be identified as malignant, gave a strongly positive reaction. The cytoplasm wAas heavily stained, with membrane accentuation (Fig. 1) . Single cells showing the same characteristics of staining and morphology were also found (Fig.  3) . These aspirates were recorded as EMA+. On some smears, there were cells or clumps of cells in which the morphology or staining was obscured by overlying cells, or the membrane accentuation was absent. An example is shown in Fig. 2 , where a clump of cells shows granular staining without membrane accentuation; in this case the Luke's preparation showed a single small clump of carcinoma. In the absence of other EMA+ cells, such aspirates were recorded as suspicious.
In total, EMA+ cells were identified in 15 aspirates, and suspicious cells or clumps ( ± ) were present in a further 6 (Tables  I & II) . Malignant cells were seen in 8 aspirates by Giemsa or Luke's preparation. Samples from all but 2 of these patients contained EMA+ cells; of these, one had cells categorized as suspicious, and the other sample was very small (Table III) . The presence and distribution of metastases in patients with positive marrow samples is shown in Table II (Table III) . Aspirates containing > 100 EMA+ cells per smear were all detected by conventional morphological methods, whereas only 2/11 aspirates containing <100 EMA+ cells were detected from Luke's or Giemsa preparations. The 2 patients without evidence of disseminated cancer had < 5 EMA+ cells per smear. In one patient with an EMA smear containing about 20 positive cells, conventional methods were negative. On repeat aspiration 4 months later, > 100 positive (Sloane et al., 1980) but it was felt that the diagnostic potential of this method was limited, because a section only allows examination of a small part of the sample.
It was necessary to remove erythrocytes from marrow aspirates in order to obtain immunocytochemical staining, and this was best achieved by density centrifugation on Lymphoprep. This also had the advantage of removing damaged cells which may stain nonspecifically, and produced an enrichment of the malignant cell population by removing some erythroid precursors and many cells of the myeloid series.
The method assumes that EMA+ cells in marrow are malignant. This has not been proved conclusively but considerable evidence from previous work has shown that EMA is only expressed by cells of epithelial or mesothelial derivation (Heyderman et al., 1979; Sloane & Ormerod, 1981) . In the present study it was found that: (1) (Riddell & Landys, 1979; Leland & Macpherson, 1979; Ingle et al., 1978; Coombes et al., 1980) . The increased diagnostic yield using trephine biopsy together with marrow aspirates has been stressed (Ingle et al., 1978; Contreras et al., 1972; Bearden et al., 1974; Leland & Macpherson, 1979; Jamshidi & Swaim, 1971; Ellis et al., 1964) but as this is at least in part due to difficulty in aspirating carcinoma cells from scirrhous tumour masses (Leland & Macpherson, 1979) it may be of less importance when attempting to detect truly micrometastatic infiltration. Our series of marrow aspirates revealed positive or suspicious cells in 19/44 (430o) of metastatic patients, but also in 3/30 (10%) of patients without conventionally demonstrable metastases at any site, including 2/20 (10%) who had primary breast carcinomas with involved axillary nodes. Although the application of immunohistochemical staining with anti-EMA in marrow trephines might further increase diagnostic yield in patients with metastatic breast cancer, this would be of little clinical consequence.
The finding of small numbers of EMA+ cells in the marrow of patients apparently free of metastases is of more interest, and requires further investigation and evaluation as to its prognostic significance. It may be possible to identify a group of poor-risk primary breast-cancer patients by directly demonstrating micrometastatic spread. Since multiple marrow biopsies have been shown to increase diagnostic yield in metastatic carcinoma (Brunning et al., 1975) we plan to evaluate the role of anti-EMA staining of multiple marrow samples in patients with primary breast carcinoma. W!e shall also compare the efficacy of trephine biopsy and aspirate in detecting small volumes of tumour infiltration. Further studies are in hand to evaluate the use of anti-EMA staining of marrows in patients with equivocal skeletal surveys or bone scans. The techniques described may also be suitable for evaluating marrow infiltration by carcinomas from many other primary sites.
